| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
5
4
5
5
3
|
|
Zacks Investment Research
5
(Strong Sell)
|
|
Standard & Poor's
5 / 5 Stars
|
|
TheStreet.com
A+
(Buy)
|
Fund Performance
The fund's Value Line Growth Persistence rank, which awards funds that consistently outperform their broad universes, is 3 for one year, 3 for five years, and 2 for 10 years. Scores are on a 1 to 5 scale, with 1 being the best and 5 the worst.
Value Line 2013-03-12
Hypothetical Growth of $10,000
Updated 04.30.2013
Trailing Total Returns
Updated 04.30.2013
| Total Return % | + / - MSCI World NR USD | + / - DJ US Health Care TR USD | % Rank | |
|---|---|---|---|---|
| Year-to-date | 18.18 | 7.05 | -1.68 | 72 |
| 1-Month | 3.26 | 0.11 | -0.03 | 62 |
| 3-Month | 10.96 | 5.22 | -0.48 | 61 |
| 6-Month | 18.91 | 4.25 | -1.63 | 77 |
| 1-Year | 26.69 | 9.99 | -3.55 | 57 |
| 3-Year (Annualized) | 17.59 | 8.00 | -0.62 | 41 |
| 5-Year (Annualized) | 11.69 | 9.88 | 0.02 | 44 |
| 10-Year (Annualized) | 11.16 | 2.87 | 2.31 | 38 |
